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Objective. Influenza vaccination rates among disadvantaged minority and hard-to-reach populations are lower than in other groups. We
assessed the barriers to influenza vaccination in disadvantaged urban areas.
Methods. We conducted a cross-sectional study, using venue-based sampling, collecting data on residents of eight neighborhoods throughout
East Harlem and the Bronx, New York City.
Results. Of 760 total respondents, 461 (61.6%) had received influenza vaccination at some point in their life. In multivariable models, having
access to routine medical care, receipt of health or social services, having tested positive for HIV, and current interest in receiving influenza
vaccination were significantly associated with having received influenza vaccination in the previous year. Of participants surveyed, 79.6% were
interested in receiving an influenza vaccination at the time of survey. Among participants who had never previously received influenza vaccination
in the past, 73.4% were interested in being vaccinated; factors significantly associated with an interest in being vaccinated were minority race,
lower annual income, history of being homeless, being uninsured/underinsured, and not having access to routine medical care.
Conclusions. Participants who are unconnected to health or social services or government health insurance are less likely to have been
vaccinated in the past although these persons are willing to receive vaccine if it were available.
© 2006 Elsevier Inc. All rights reserved.Keywords: Influenza; Vaccination; Hard-to-reach populations; Urban; DisadvantagedIntroduction
Every year, 10–20% of the American population falls ill with
influenza (Couch, 1993), and an estimated 36,000 persons die
from influenza-related complications (Thompson et al., 2003).
Vaccination is known to reduce morbidity and mortality from
respiratory infections that arise secondary to influenza infection
(Barker andMullooly, 1980; Fedson, 1987). Although those age
65 and older have accounted for over 90% of influenza-related⁎ Corresponding author. Department of Epidemiology, University of Michi-
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influenza has been associated with increased incidence of upper
respiratory illness, physician visits, and the number of sick days
in healthy adults under 65 years of age. As such, the American
College of Preventive Medicine and the CDC's Advisory
Committee on Immunization Practices (ACIP) recommends
annual vaccination for all persons at high risk for complications
from influenza infection without a medical contraindication.
This includes adults aged 65 and older as well as those with a
variety of very common chronic medical conditions such as
diabetes mellitus, asthma, and heart disease. Adults aged 50 to
64 have recently been added to those recommended for flu
vaccination because of the significant prevalence of these high-
risk conditions in that age group (Centers for Disease Control,
61W.K. Bryant et al. / Preventive Medicine 43 (2006) 60–702005; Bridges et al., 2000; Nichol et al., 1995). The influenza
vaccination rate among persons over the age of 65 was recently
reported as 66%; this rate was lower among Hispanics (54%)
and African-Americans (48%) than among Whites (66%)
(Centers for Disease Control, 2005). Several studies have
shown, however, that influenza vaccination rates among high-
risk elderly persons can be as low as 20%, even in patients in
health maintenance organizations (Mullooly et al., 1994; Figaro
and Belue, 2005). Rates for younger persons in high-risk groups
have been shown to be even lower (Figaro and Belue, 2005).
Minorities tend to have lower influenza vaccination rates
than non-minorities, a disparity that exists for all age groups,
including the elderly covered by Medicare, and those who are
directly targeted by public health interventions (Lashuay et al.,
2000; Ostbye et al., 2003; Collins et al., 1999). Although overall
rates of vaccination in the elderly have been on the rise in the
last decade, the disparities among ethnic groups have persisted:
Hispanic elderly are less likely than white elderly to receive
influenza vaccination every year and African-American elderly
are even less likely (Hargraves, 2001). Differences in vac-
cination rates between high-risk whites and African-Americans,
at any age, persist through all demographic strata, including
those related to health care access and perceived health status
(Egede and Zheng, 2003; Marin et al., 2002). Inner city elderly,
and a large proportion of those living in disadvantaged urban
neighborhoods have consistently lower rates of influenza
vaccination than those not living in areas of disadvantage,
even when race is taken into account (Zimmerman et al., 2003;
Nowalk et al., 2004).
Although data are sparse, other hard-to-reach sub-groups such
as elderly shut-ins, active injection drug users, sex workers, and
undocumented immigrants may be even less likely to receive
regular influenza vaccination despite high risk of morbidity and
mortality secondary to influenza. A number of the medical
conditions for which influenza vaccination is recommended, such
as diabetes mellitus, heart disease, and asthma, are also more
prevalent in these groups. In addition, low socioeconomic status
urban populations are at increased risk of morbidity and mortality
when immunization rates are low (Task Force on Community
Preventive Services, 2000). Many members of these hard-to-
reach groups are at increased risk of morbidity and mortality due
to influenza as a result of factors ranging from low socioeconomic
status, increased risk of immunocompromise due to lifestyle, and
increased incidence and prevalence of high risk comorbidities
such as asthma and diabetes.
One of the goals of Healthy People 2010 is to raise the rate of
influenza vaccination in high-risk adults to 60%, and for in-
stitutionalized high-risk adults and all those over age 65, to 90%
(Department of Health and Human Services, 2000). Attaining
these goals, however, has proved a challenge for the US public
health system, which has been highlighted by the national
influenza vaccine shortage of 2004. In order to address the
dearth of data on the topic, we aimed to assess the barriers to
immunization among hard-to-reach populations in disadvan-
taged minority communities. Comparable assessments of per-
sonal and structural barriers to preventive health behaviors such
as influenza vaccination in this population are scarce. Othershave not looked at populations like this in ways that can
differentiate the importance of these barriers and their effects in
vaccination rates. In the recently released draft US government
“Pandemic Influenza Response and Preparedness Plan,” little
attention is paid to the problem of persistently low influenza
vaccination rates in disadvantaged populations. The draft en-
courages state and local government to “identify potential
barriers to vaccination of racial and ethnic minority populations
and develop strategies to overcome them” (Department of
Health and Human Services, 2004). This study is an attempt to
do that on a broader scale, to identify the relative contributions
of personal factors and structural barriers to influenza vac-
cination in disadvantaged urban populations.
Methods
Study population
The communities of East Harlem and the Bronx are among the most socio-
economically disadvantaged communities in New York City. These neighbor-
hoods also have high disease morbidity, including some of the highest HIV
incidence rates in the city, as well as higher rates of asthma and diabetes mellitus
than the general population of the city. Our study was carried out in three
neighborhoods in East Harlem and five in the Bronx. These neighborhoods are
areas of particular disadvantage across their larger boroughs. Neighborhood
boundaries were defined by a process of consultation with East Harlem and
Bronx community members as part of a project that will eventually distribute
influenza vaccinations to marginalized groups.
Subject recruitment
This project sought to recruit members of hard-to-reach populations, not
members of the general population, in each of these eight East Harlem and
Bronx neighborhoods of New York City. First, we collaborated with community
members to conduct ethnographic assessments on areas within these neighbor-
hoods with high population presence of these groups. Second, we recruited
participants using venue-based sampling. Our venues included places fre-
quented by members of our study population (e.g., elderly shut-ins active
injection drug users, sex workers, and undocumented immigrants), including
drug outreach centers, shooting galleries, places were sex workers solicited, and
meeting places for undocumented immigrants to find off-the-books employ-
ment. These more specific areas included the sites of previous research by our
team using street outreach described elsewhere (Ompad et al., 2004; Diaz et al.,
2001a,b). The study was approved by the institutional review board of the New
York Academy of Medicine.
Data collection
In February, March and April of 2004, bilingual outreach workers ap-
proached participants in each neighborhood and administered a brief survey
about participants' vaccination histories and perceived barriers to vaccination.
All persons encountered during this enumeration phase were asked to complete
the survey. The survey was only administered to those aged 18 or older.
Participants were not paid for completing the interview. The survey instrument
assessed age, gender, race, marital status, recent and lifetime homelessness,
recent and lifetime hunger sources of income, history of medical conditions
which would indicate influenza vaccination, history of influenza vaccination,
and interest in receiving influenza vaccination. Interest in vaccination was
determined by asking, “Are you interested in taking a flu shot?” Recent
influenza vaccination was defined as having received a vaccination at any time
during from fall of 2003 to spring of 2004. The questions on access to health
care addressed insurance and type, regularity and location of access to health
care, and receipt of services from government or community agencies. For those
reporting more than one type of health insurance, we classified them according
Table 1
Correlates of lifetime influenza vaccination among residents of East Harlem and the Bronx a
Characteristic Total sample Ever had flu vaccine P value Adjusted odds ratio
n % n % (95% CI)
Age
18 to 29 192 25.3 107 55.7 0.0001 1.0
30 to 39 195 25.7 106 54.4 0.79 (0.50, 1.25)
40 to 49 186 24.5 114 61.3 0.88 (0.54, 1.44)
50 to 64 127 16.8 95 74.8 1.86 (1.04, 3.31)
65 and older 58 7.7 45 77.6 1.90 (0.82, 4.41)
Gender
Male 340 45 201 59.1 0.222
Female 416 55 264 63.5
Racial/ethnic background
White 27 3.6 17 63.0
Hispanic or Latino 574 75.9 352 61.3 0.9141
African-American 132 17.5 84 63.6
Other 23 3.0 13 56.5
Marital status
Single, never married 390 51.7 248 63.6 0.1479
Divorced 74 9.8 48 64.9
Separated 59 7.8 35 59.3
Widowed 34 4.5 26 76.5
Married or common law 174 23.1 95 54.6
Domestic partnership 23 3.1 13 56.5
Total legal income
No income 191 25.1 90 47.1 b0.0001 1.0
$1 to $4800/year 165 21.7 115 69.7 1.61 (0.96, 2.71)
$4801 to $9600/year 178 23.4 119 66.9 1.36 (0.80, 2.31)
$9601/year and up 183 24.1 113 61.7 1.37 (0.81, 2.30)
Missing 43 5.7 31 72.1 2.05 (0.88, 4.79)
Housing type
Homeless 83 11.2 57 68.7 0.4802
Transitional 122 16.4 77 63.1
Institutional 13 1.8 7 53.8
Stable 524 70.6 317 60.5
Ever been homeless
Yes 285 38.5 192 67.4 0.0099 1.0
No 456 61.5 264 57.9 0.92 (0.61, 1.40)
Ever hungry in past 6 months
Yes 220 29.3 129 58.6 0.3104
No 532 70.7 333 62.6
Health insurance status
None 235 31.3 102 43.4 b0.0001 1.0
Medicaid 312 41.5 232 74.4 1.98 (1.25, 3.15)
Medicare 42 5.6 32 76.2 1.67 (0.67, 4.13)
Private insurance/HMO 76 10.1 40 52.6 0.96 (0.51, 1.84)
Other 87 11.6 57 65.5 1.91 (1.04, 3.50)
Receives routine medical care
Yes 529 70.3 367 69.4 b0.0001 1.0
No 224 29.8 97 43.3 0.51 (0.34, 0.76)
Ever received health/social services from government agency
Yes 454 59.9 314 69.2 b0.0001 1.0
No 304 40.1 153 50.3 0.85 (0.57, 1.26)
Ever received health or social services from a community agency
Yes 269 35.6 181 67.3 0.0177 1.0
No 487 64.4 285 58.5 1.03 (0.68, 1.66)
Ever injected drugs
Yes 95 12.6 67 70.5 0.0604 1.0
No 661 87.4 400 60.5 0.88 (0.47, 1.65)
Injected drugs in the past 6 months
Yes 42 5.5 25 59.5 0.7835
No 717 94.5 442 61.6
Ever traded sex
Yes 54 7.2 38 70.4 0.1700
No 699 92.8 426 60.9
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Table 1 (continued)
Characteristic Total sample Ever had flu vaccine P value Adjusted odds ratio
n % n % (95% CI)
Traded sex in the past 6 months
Yes 18 2.4 12 66.7 0.6471
No 740 97.6 454 61.4
Ever had a hepatitis vaccine
Yes 350 49.4 255 72.9 b0.0001
No 359 50.6 179 49.9
HIV status
Positive 33 4.5 30 90.9 1.0
Never tested 203 27.8 95 46.8 b0.0001 0.15 (0.04, 0.58)
Negative 494 67.7 323 65.4 0.26 (0.07, 0.97)
Medically indicated to receive flu vaccine
No 411 54.1 226 55.0 b0.0001
Yes 349 45.9 242 69.3 1.36 (0.95, 1.95)
Interested in taking flu vaccine
Yes 576 79.6 375 65.1 0.0012
No 148 20.4 75 50.7
Reason why did not want flu shot
You think the vaccine is not safe 21 16.8 11 52.4 b0.0001
You do not like injections 28 22.4 12 42.9
You have a medical reason that
conflicts with getting a vaccine
13 10.4 9 69.2
You are not at high risk 24 19.2 2 8.3
You already had vaccine this year 19 15.2 18 94.7
Other 20 16.0 12 60.0
a Due to missing values, the numbers in some of the cross tabulations presented in this table may not add up to the total sample size.
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in the survey were (i) history of recent immunizations, (ii) key perceived barriers
to obtaining vaccination, (iii) primary reasons for accepting or not accepting
vaccination, and (iv) principal health conditions, including morbidity and factors
that determine eligibility for influenza vaccination.
Statistical methods
We summarized socio-demographic variables, access to health care, drug-
related and sex-related risk behaviors, vaccination history, HIV status, interest in
receiving an influenza vaccination, and, if they were not interested in influenza
vaccination, their reasons for non-interest. We calculated the total number and
proportion of the sample that had ever had an influenza vaccination, and used
chi-square tests when comparing vaccination status by covariates to assess
significance in the differences between those who had ever had an influenza
vaccination and those who had not. We used logistic regression to assess
relations between the above characteristics and the likelihood of ever having
received an influenza vaccination. All covariates that were significantly
associated (P b 0.1) with receiving an influenza vaccination in bivariate
analysis were included in multivariate models.
We calculated the total number and proportion of the sample that had their
influenza vaccination in the past year (Fall 2003 to Spring 2004) or prior to the past
year (before Fall 2003), and used chi-square tests when comparing vaccination
status by covariates to assess significance in the differences between the two
groups. We used logistic regression to assess relations between the covariates of
interest and the likelihood of having received an influenza vaccination in the past
year. All covariates that were significantly associated (P b 0.1) with receiving an
influenza vaccination in bivariate analysis were included in multivariate models.
We examined the characteristics of those who were not interested in an
influenza vaccination at the time of the survey, and their reasons. We excluded
those who did not want the vaccine because they had had it during the current
influenza season. We calculated the total number and proportion of this sub-
sample who were interested in having an influenza vaccination and those who
were not, and used chi-square tests when comparing vaccination status by
covariates to assess significance in the differences between the two groups. Weused logistic regression to assess relations between the covariates of interest and
the likelihood of wanting influenza vaccination at the time of the survey. Finally,
we assessed reasons for not being interested in influenza vaccination among
those who had never had an influenza vaccination. We calculated the total
number and proportion of the sub-sample who were not interested because they
felt the vaccine was not safe, because they hate injections or needles, because
they had a medical reason that would conflict with receiving the vaccine, and
because they perceived themselves to be at low risk. We used chi square tests to
assess significance in the differences among the groups.
Results
Among 760 respondents surveyed, 468 (61.6%) had ever had
an influenza vaccination. Table 1 shows the characteristics and
bivariate correlates of having ever had an influenza vaccination.
Of the 61.6% of this sample who had ever had an influenza
vaccination, 51.4% were vaccinated in the last year (Fall 2003–
Spring 2004) (data not shown). When asked if they were
interested in having an influenza vaccination at the time of the
survey, 79.6% of all respondents said they were. Among those
who were not interested in receiving an influenza vaccine,
16.8% said it was because they did not think the vaccine was
safe, 22.4% said it was because they hate injections, 10.4% said
it was because they had a medical contraindication to the
influenza vaccination, and 19.2% said it was because they felt
they were at low risk. Other reasons for not wanting the vaccine
comprised the remaining 30.2% of responses.
Sociodemographic covariates significantly associated with
greater likelihood of having ever received an influenza vaccination
were older age (77.6% for age group 65 and older, 74.8% for age
group 50–64, 61.3% for age group 40–40, 54.4% for age group
Table 2
Correlates of recent influenza vaccination among hard-to-reach residents of East Harlem and the Bronx who have previously received influenza vaccination a
Characteristic Total Last shot this
year
P value Logistic regression model for recent
influenza vaccination adjusted odds ratio
n n % (95% CI)
Age
18 to 29 92 22 40 43.5 0.3897
30 to 39 94 22.4 48 51.1
40 to 49 102 24.3 53 52.0
50 to 64 91 21.7 52 57.1
65 and older 40 9.6 23 57.5
Gender
Male 180 43.2 92 51.1 0.9410
Female 237 56.8 122 51.5
Racial/ethnic background
White 17 4.1 5 29.4
Hispanic or Latino 319 76.3 169 53.0 0.289
African-American 69 16.5 36 52.2
Other 13 3.1 6 46.2
Marital status
Single, never married 217 51.9 104 47.9 0.0856 1
Divorced 44 10.5 24 54.5 1.07 (0.51, 2.23)
Separated 32 7.7 18 56.3 1.05 (0.46, 2.40)
Widowed 25 6 17 68.0 1.93 (0.74, 5.00)
Married or common law 88 21.1 42 47.7 0.96 (0.55, 1.67)
Domestic partnership 12 2.9 10 83.3 5.00 (0.95, 26.12)
Total legal income
No income 76 18.1 35 46.1 0.6863
$1 to $4800/year 110 26.2 58 52.7
$4801 to $9600/year 105 25 57 54.3
$9601/year and up 104 24.8 51 49.0
Missing 25 6 15 60.0
Housing type
Homeless 53 12.8 21 39.6 0.3732
Transitional 70 16.9 31 44.3
Institutional 7 1.7 4 57.1
Stable 284 68.6 145 51.1
Ever been homeless
Yes 177 43.1 99 55.9 0.088 1
No 234 56.9 111 47.4 0.76 (0.47, 1.23)
Ever hungry in past 6 months
Yes 121 29.1 60 49.6 0.6277
No 295 70.9 154 52.2
Health insurance status
None 82 19.7 33 40.2 0.0784 1
Medicaid 218 52.4 122 56.0 1.14 (0.61, 2.14)
Medicare 30 7.2 14 46.7 1.07 (0.40, 2.86)
Private insurance/HMO 35 8.4 22 62.9 2.20 (0.88, 5.51)
Other 51 12.3 24 47.1 1.22 (0.54, 2.74)
Receives routine medical care
Yes 335 80.5 189 56.4 0.0002 1
No 81 19.5 27 33.3 0.48 (0.26, 0.88)
Ever received health/social services from government agency
Yes 288 68.6 150 52.1 0.6917
No 132 31.4 66 50.0
Ever received health/social services from a community agency
Yes 165 39.5 92 55.8 0.1773
No 253 60.5 124 49.0
Injected drugs in the past 6 months
Yes 22 5.3 18 81.8 0.0033 1
No 397 94.8 197 49.6 0.17 (0.04, 0.80)
Ever traded sex
Yes 32 7.7 15 46.9 0.6007
No 385 92.3 199 51.7
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Table 2 (continued)
Characteristic Total Last shot this
year
P value Logistic regression model for recent
influenza vaccination adjusted odds ratio
n n % (95% CI)
Traded sex in the past 6 months
Yes 9 2.2 4 44.4 0.7451
No 409 97.9 211 51.6
Ever had a hepatitis vaccine
Yes 231 59.1 125 54.1 0.2441
No 160 40.9 77 48.1
HIV status
Positive 27 6.7 24 88.9 1
Never tested 82 20.4 33 40.2 b0.0001 0.13 (0.03, 0.51)
Negative 294 73 152 51.7 0.20 (0.06, 0.71)
Medically indicated to receive flu vaccine
No 191 44.5 95 49.7 0.5267
Yes 229 54.5 121 52.8
Interested in taking flu vaccine
Yes 339 83.9 185 54.6 0.0172
No 65 16.1 25 38.5
If did not want flu vaccine, reason why not
You think the vaccine is not safe 11 19 4 36.4 0.2735
You do not like injections 11 19 5 45.5
You have a medical reason that conflicts
with getting a vaccine
8 13.8 1 12.5
You already had vaccine this year 15 25.9 6 40.0
Other 11 19 3 27.3
a Due to missing values, the numbers in some of the cross tabulations presented in this table may not add up to the total number of participants in this table's subset.
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legal annual income (69.7% for those earning $1–$4800, 66.9% for
those earning $4801–$9600, and 61.7% for those earning $9601 or
more vs. 47.1% for those with no income; P b 0.001), and having
ever been homeless (67.4% vs. 57.9% for those who had never
been homeless; P = 0.01). Health care access covariates signi-
ficantly associated with ever having received an influenza vaccina-
tion were health insurance status (74.4% for those with Medicaid,
76.2% for those with Medicare, 52.6% for those with private
insurance, and 65.5% for those with some other type of insurance
vs. 43.4% for thosewith no insurance;Pb 0.001), receiving routine
medical care (69.4% vs. 43.3% for those who do not; P b 0.001),
receiving health or social services from a government agency
(69.2% vs. 50.3% for those who had not; P b 0.001), receiving
health or social services from a community agency (67.3% vs.
58.5% for thosewho had not;P=0.018), and having tested positive
for HIV (90.9% vs. 65.4% for those who had tested negative and
46.8% for those who had never been tested; P b 0.001). Among
vaccination-related covariates, significantly associated with greater
likelihood of having ever received an influenza vaccination was
being interested in an influenza vaccination at the time of the survey
(65.1%vs. 50.7% for thosewhowere not;P=0.001), and reporting
amedical condition, except forHIV,whichwould indicate vaccina-
tion (63.9% for those who would be medically indicated for
vaccination vs. 55.0% for those who would not; P b 0.001).
Table 1 also shows the results of multivariate models of
correlates of ever having had an influenza vaccination. In a
multivariate logistic regression model, variables that were
significantly associated with a greater likelihood of havingever had the influenza vaccine were: being in the 50–64 age
group (adjusted odds ratio (AOR) = 1.86, 95% Confidence
Interval (CI) = 1.04–3.31), and receiving Medicaid
(AOR = 1.98, 95% CI = 1.25–3.15). Variables significantly
associated with a lower likelihood of having ever had an
influenza vaccination were not receiving routine medical care
(AOR = 0.51, 95% CI = 0.34–0.76) and having never been
tested (AOR = 0.15, 95% CI = 0.04–0.58), or tested negative
(AOR = 0.26, 95% CI = 0.72–0.97) for HIV. Unadjusted odds
ratios are not shown.
Table 2 shows the bivariate correlates for having been vac-
cinated in the last year among those who have ever had an
influenza vaccination (Fall 2003–Spring 2004) or before last
year (prior to Fall 2003). The covariates significantly associated
with having had an influenza vaccination in the past year were:
receiving routine medical care (56.4% vs. 33.3% for those who
did not; P = 0.001), having ever injected drugs (69.8% vs. 48.2%
for those who had never; P = 0.002), injecting drugs in the past 6
months (81.8% vs. 49.6% for those who did not; p 0.003), testing
positive for HIV (88.9% vs. 40.2% for never been tested and
51.7% for testing negative;P b 0.001), and being interested in an
influenza vaccination at the time of survey (54.6% vs. 38.5% for
those who were not; P = 0.017). In the multivariate logistic
regression, the variables significantly associated with a lower
likelihood of having had an influenza vaccination in the most
recent year were not receiving routine medical care (AOR = 0.48,
95% CI = 0.26–0.88), report of no illicit drug injection within the
past 6 months (AOR = 0.17, 95% CI = 0.04–0.80), and never
being tested or having tested negative for HIV (AOR = 0.13, 95%
Table 3





P value Unadjusted odds ratio
n % n % 95% CI
Age
18 to 29 56 70.9 23 29.1 0.2011 1
30 to 39 68 81.9 15 18.1 1.86 (0.89, 3.90)
40 to 49 45 66.2 23 33.8 0.80 (0.40, 1.62)
50 to 64 24 77.4 7 22.6 1.41 (0.53, 3.72)
65 and older 7 63.6 4 36.4 0.72 (0.19, 2.69)
Gender
Male 106 79.1 28 20.9 0.04 1
Female 94 68.1 44 31.9 0.56 (0.32, 0.97)
Racial/ethnic background
White 2 22.2 7 77.8 1
Hispanic or Latino 167 79.1 44 20.9 0.0003 13.27 (2.66, 66.12)
African-American 26 61.9 16 38.1 5.68 (1.05, 30.80)
Other 6 66.7 3 33.3 6.99 (0.86, 56.83)
Marital status
Single, never married 98 74.2 34 25.8 0.5186 1
Divorced 16 66.7 8 33.3 0.69 (0.27, 1.77)
Separated 14 60.9 9 39.1 0.54 (0.21, 1.36)
Widowed 5 71.4 2 28.6 0.87 (0.16, 4.68)
Married or common law 59 79.7 15 20.3 1.37 (0.69, 2.72)
Domestic partnership 8 80.0 2 20.0 1.39 (0.28, 6.86)
Total legal income
No income 78 81.3 18 18.8 0.0342 1
$1 to $4800/year 38 79.2 10 20.8 0.88 (0.37, 2.08)
$4801 to $9600/year 40 70.2 17 29.8 0.54 (0.25, 1.17)
$9601/year and up 37 59.7 25 40.3 0.34 (0.17, 0.70)
Missing 8 80.0 2 20.0 0.92 (0.18, 4.72)
Housing type
Homeless 22 84.6 4 15.4 0.4467 1
Transitional 31 77.5 9 22.5 0.63 (0.17, 2.29)
Institutional 4 66.7 2 33.3 0.36 (0.05, 2.70)
Stable 138 71.1 56 28.9 0.45 (0.15, 1.36)
Ever been homeless
Yes 72 82.8 15 17.2 0.0191 1
No 124 69.3 55 30.7 0.47 (0.25, 0.89)
Ever hungry in past 6 months
Yes 69 80.2 17 19.8 0.1006 1
No 131 70.8 54 29.2 0.60 (0.32, 1.11)
Health insurance status
None 104 81.3 24 18.8 0.0033 1
Medicaid 55 72.4 21 27.6 0.60 (0.31, 1.18)
Medicare 7 70.0 3 30.0 0.54 (0.13, 2.24)
Private insurance/HMO 15 46.9 17 53.1 0.20 (0.09, 0.46)
Other 18 75.0 6 25.0 0.69 (0.25, 1.93)
Receives routine medical care
Yes 99 67.8 47 32.2 0.0259 1
No 99 79.8 25 20.2 1.88 (1.07, 3.29)
Ever received health/social services from government agency
Yes 88 68.8 40 31.3 0.0921 1
No 112 77.8 32 22.2 1.59 (0.93, 2.74)
Ever received health or social services from a community agency
Yes 67 79.8 17 20.2 0.1138 1
No 132 70.6 55 29.4 0.61 (0.33, 1.13)
Ever injected drugs
Yes 22 81.5 5 18.5 0.3332 1
No 177 72.8 66 27.2 0.61 (0.22, 1.68)






P value Unadjusted odds ratio
n % n % 95% CI
Injected drugs in the past 6 months
Yes 14 82.4 3 17.6 0.5721 1
No 187 73.0 69 27.0 0.58 (0.16, 2.08)
Ever traded sex
Yes 13 81.3 3 18.8 0.571 1
No 185 72.8 69 27.2 0.62 (0.17, 2.24)
Traded sex in the past 6 months
Yes 5 83.3 1 16.7 1 1
No 196 73.4 71 26.6 0.55 (0.06, 4.81)
Ever had a hepatitis vaccine
Yes 61 70.1 26 29.9 0.3316 1
No 131 75.7 42 24.3 1.33 (0.75, 2.36)
HIV status
Positive 2 66.7 1 33.3 1
Never tested 84 81.6 19 18.4 0.0701 2.21 (0.19, 25.66)
Negative 108 68.8 49 31.2 1.10 (0.10, 12.44)
a Due to missing values, the numbers in some of the cross tabulations presented in this table may not add up to the total number of participants in this table's subset.
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spectively). Unadjusted odds ratios are not shown.
Table 3 shows the correlates of interest in receiving an
influenza vaccination at the time of the survey among those who
have never had an influenza vaccination (N = 273). Significant
covariates were: being a racial minority (79.1% for Hispanics/
Latinos, 61.9% for African-Americans, and 66.7% Other vs.
22.2% for Whites; P = 0.001), having lower annual income
(81.3% of those with no income, 79.2% of those earning $1–
$4800, 70.2% of those earning $4801–$9600, and 59.7% for
those earning $9601 or more; P = 0.034), having ever been
homeless (82.8% vs. 69.3% of those who had not; P = 0.012),
having no health insurance or government insurance (81.3% for
those with no insurance, 72.4% for those with Medicaid, and
70.0% for those with Medicare vs. 46.9% for those with private
insurance; P = 0.003), and not receiving routine medical care
(79.8% vs. 69.8% for those who did; P = 0.026).
Table 4 shows the correlates of the reasons respondents gave
for why they were not interested in receiving an influenza
vaccination, among those who were not interested in one at time
of the survey (N = 113). Participants who had ever had an
influenza vaccination were more likely to say that the vaccine is
not safe (24.4%) and that they hate injections (26.7%) as the
reason for their disinterest in a vaccination at the time of
interview. Among those who had never had an influenza
vaccination, the most likely reasons for lack of interest were that
they were at low risk (34.4%), and, similar to the previous
group, that they disliked injections (25.0; P = 0.001).
Discussion
Among residents of eight disadvantaged neighborhoods in
East Harlem and the Bronx, New York City, we found that 62%
had received one influenza vaccination at least once in their
lifetime. We found that persons who were less likely to have everhad an influenza vaccination were younger, had lower income,
did not have health insurance, had no access to routine medical
care, and were not receiving other health or social services.
Determinants of receiving a recent influenza vaccination
included having routine access to medical care, injection drug
use, and HIV-positive serostatus. We found that those who
wanted the vaccine at the time of the survey were more likely to
be racial minorities, to have a lower annual income, to have a
history of homelessness, and to lack a source of routine medical
care.
Our findings are congruent with studies that have found that
persons who are vaccinated are older, are more likely to have a
higher rate of access to medical care, and have a higher number of
annual physician visits (Nowalk et al., 2004; Wilson et al., 2002;
Pena-Rey et al., 2004; Petersen et al., 1999; Nichol et al., 1992;
Chapman and Coups, 1999; Carter et al., 1986). It is possible that
this is the result of a greater likelihood, with age, of receiving care
for chronic illness and being prioritized by caregivers for receipt
of vaccine.We observed a lower likelihood of vaccination among
those with no access to routine medical care. This observation
contrasts with studies that suggest that lack of access to routine
medical care is not a barrier to vaccination (Santibanez et al.,
2002; Frank et al., 1985). However, most previous studies were
conducted in elderly populations; this is in contrast to our sample
in which fewer than 8% of respondents were over age 65. Other
work provides corroborating evidence that health care providers
of hard-to-reach populations may be in a unique position to
deliver vaccines to these groups. Seventy-one percent of partici-
pants in one study of intravenous drug-users said they would have
accepted a vaccine if asked (Seal et al., 2000). Other studies
confirm that the recommendation of a health professional is the
greatest single determinant of whether people, from a variety of
backgrounds, are vaccinated (Duclos and Hatcher, 1993; Nowalk
et al., 2004; Lashuay et al., 2000; Chapman and Coups, 1999;
Wilson et al., 2002; Figaro and Belue, 2005). Given that 70.3% of
Table 4










n % n % n % n %
Age
18 to 29 8 23.5 11 32.4 1 2.9 7 20.6 0.4385
30 to 39 3 13.0 5 21.7 3 13.0 5 21.7
40 to 49 9 25.0 7 19.4 6 16.7 10 27.8
50 to 64 2 14.3 2 14.3 4 28.6 2 14.3
65 and older 1 16.7 3 50.0 0 0.0 1 16.7
Gender
Male 7 18.9 6 16.2 6 16.2 9 24.3 0.4918
Female 16 21.1 22 28.9 8 10.5 16 21.1
Racial/ethnic background
Hispanic or Latino 16 21.9 18 24.7 12 16.4 13 17.8 0.2189
African-American 4 14.8 9 33.3 2 7.4 7 25.9
White 1 12.5 0 0.0 0 0.0 4 50.0
Other 0 0.0 1 50.0 0 0.0 1 50.0
Total legal income
No income 5 21.7 6 26.1 2 8.7 7 30.4 0.169
$1 to $4800/year 5 27.8 5 27.8 3 16.7 0 0.0
$4801 to $9600/year 6 22.2 5 18.5 4 14.8 8 29.6
$9601/year and up 7 17.5 8 20.0 5 12.5 10 25.0
Missing 0 0.0 4 80.0 0 0.0 0 0.0
Ever been homeless
Yes 9 28.1 7 21.9 3 9.4 4 12.5 0.3493
No 14 17.9 20 25.6 11 14.1 20 25.6
Ever hungry in past 6 months
Yes 5 20.0 5 20.0 4 16.0 6 24.0 0.8263
No 18 20.9 23 26.7 9 10.5 19 22.1
Health insurance status
None 8 25.0 8 25.0 5 15.6 7 21.9 0.2313
Medicaid 9 23.1 9 23.1 4 10.3 7 17.9
Medicare 0 0.0 0 0.0 3 50.0 1 16.7
Private insurance/HMO 4 18.2 8 36.4 1 4.5 5 22.7
Other 2 15.4 3 23.1 1 7.7 4 30.8
Ever had a flu vaccine
Yes 11 24.4 12 26.7 9 20.0 2 4.4 0.0011
No 10 15.6 16 25.0 4 6.3 22 34.4
Do not know 2 100.0 0 0.0 0 0.0 0 0.0
When received last flu vaccine
Never received one 10 15.6 16 25.0 4 6.3 22 34.4 0.0029
This year (Fall, 2003–Spring, 2004) 4 25.0 5 31.3 1 6.3 2 12.5
Before this year (pre-Fall 03) 7 30.4 6 26.1 7 30.4 0 0.0
HIV status
Never tested 5 20.8 7 29.2 2 8.3 7 29.2 0.6829
Positive 0 0.0 1 50.0 1 50.0 0 0.0
Negative 18 21.4 19 22.6 11 13.1 16 19.0
a Participants could only select one reason why they did not want a flu vaccine.
b Due to missing values, the numbers in some of the cross tabulations presented in this table may not add up to the total number of participants in this table's subset.
c Percentages presented are row percents.
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venue for increasing influenza vaccination should be underscored.
Our findings concur with those who have found that the
unvaccinated, and those who do not want a vaccination,
often think they are at low risk, particularly those at high
risk of morbidity and mortality due to influenza (Santibanez
et al., 2002; Seal et al., 2000; Centers for Disease Control,
1997). Our findings also agree with previous observations
that persons who believe that the influenza vaccination is
not safe are more likely never to have been vaccinated, or at
least not to have been vaccinated in the past 12 months(Figaro and Belue, 2005; Wilson et al., 2002). Congruent
with previous work, we found that mistrust of the health
care system or providers of government or community
services was not a substantial barrier to immunization
(Santibanez et al., 2002). Most participants believed these
groups have their best interests in mind. One factor not
assessed by our study that could be a barrier to vaccination
was whether respondents were ambulatory and able to get to
the point of vaccine delivery. This is a possible avenue for
future research, particularly for members of this population
who are elderly or disabled.
69W.K. Bryant et al. / Preventive Medicine 43 (2006) 60–70Our data suggest that one key method to increase influenza
vaccination rates in disadvantaged urban populations is through
affiliation with health and social services. Innovative studies that
have linked influenza vaccine delivery with less traditional ser-
vices have shown promise in delivering vaccine to hard-to-reach
populations. Some pilot projects have shown success in vacci-
nating hard-to-reach populations through harm reduction sites,
emergency rooms, and other venues (Grau et al., 2002; Stancliff et
al., 2000; Slobodkin et al., 1998; Solomon et al., 1991). Changing
attitudes about side effects of influenza vaccination has been
shown to improve vaccination rates, as has offering different
forms of vaccine administration, such as a nasal spray, to those
who dislike injections (Buchner et al., 1985). Some studies have
shown that African-Americans who were able to access primary
care received preventive services at rates equal to or greater than
white patients, including immunizations (Williams et al., 2001;
Wright et al., 2000).
Our results must be interpreted with caution. Because we
relied on self-reported data, we have no way of confirming
if the reports of receiving influenza vaccination, or other
variables, were accurate. Also, it is possible that these
results are not generalizable to other hard-to-reach popula-
tions in the city, with differing demographic compositions,
or to cities other than New York City. Our study considered
reasons for not wanting an influenza vaccination; however,
we did not consider reasons why persons may want
influenza vaccination. Since no one really knows the true
make-up of this hard-to-reach population, it is difficult to
say if our sample was representative of that population. It is
also difficult to say if those who agreed to participate in our
survey differed from those who refused. However, based on
our conclusions, and the validation of our methods in other
studies (Diaz et al., 2001a,b), we feel our results stand.
Another possible limitation of our study is the relatively low
number of white subjects (N = 27, 3.6%). Because of this,
one must be careful in drawing conclusions about minority
subjects relative to whites.
Low vaccination rates may be attributable to poor communica-
tion to populations of risk regarding both the risks of influenza, and
the side effects of the vaccination. In one study of the elderly, half
received all their health information from their physician and half
from books, television, the Internet, and other media, suggesting an
important role for dissemination vaccination-related information
through less traditional outlets (Santibanez et al., 2002).
Our findings suggest that connectingmembers of hard-to-reach
populations to government or community social services may be
one way to greatly improve influenza vaccination rates. The fact
that more than three quarters of survey respondents were in-
terested in receiving influenza vaccine at the time of survey,
whether connected to social services or not, indicates it may be
possible to conduct well-received influenza vaccination cam-
paigns in this population. A high reported rate of routine access to
medical care among the population studied implies that health care
providersmaybe the best route to increasing influenza vaccination
in this group. Our findings suggest that there is an unmet need for
influenza vaccine particularly among those persons who have
been homeless, uninsured, and receive little or no income.Acknowledgments
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